CEIT-Cancer specifications

Information


Unique identifier OMICS_32180
Name CEIT-Cancer
Alternative name Comparative Effectiveness of Innovative Treatments for Cancer
Restrictions to use None
Community driven No
Data access Browse
User data submission Not allowed
Maintained Yes

Maintainer


  • person_outline Lars Hemkens

Publication for Comparative Effectiveness of Innovative Treatments for Cancer

CEIT-Cancer institution(s)
Basel Institute for Clinical Epidemiology and Biostatistics, Department of Clinical Research, University Hospital and University of Basel, Basel, Switzerland; Swiss Tropical and Public Health Institute (Swiss TPH), Basel, Switzerland; University Rennes, CHU Rennes, Inserm, CIC 1414 (Centre d’Investigation Clinique de Rennes), Rennes, France; Department of Medicine, University of Toronto, Toronto, ON, Canada; Department of Health Research Methods, Evidence and Impact, McMaster University, Hamilton, ON, Canada; Health Technology Assessment Unit, Institute of Education and Health Sciences, Oswaldo Cruz German Hospital, São Paulo, Brazil; Department of Medicine, The Royal Marsden NHS Foundation Trust, Downs Road, Sutton, UK; Catalan Institute of Oncology (ICO) Hospitalet, Melanoma, Sarcoma and GU Tumors Unit, Barcelona, Spain; Vall d’Hebron Institute of Oncology (VHIO), Early Drug Development Unit (UITM), Pg Vall d’Hebron, Barcelona, Spain; Clara Hospital, Basel, Switzerland; University Medical Library, University of Basel, Basel, Switzerland; Meta-Research Innovation Center at Stanford (METRICS), Stanford University, Stanford, CA, USA; Department of Medicine, Stanford University School of Medicine, Stanford, CA, USA; Department of Health Research and Policy, Stanford University School of Medicine, Stanford, CA, USA; Department of Biomedical Data Science, Stanford University School of Medicine, Stanford, CA, USA; Department of Statistics, Stanford University School of Humanities and Sciences, Stanford, CA, USA; Medical Oncology, University Hospital and University of Basel, Basel, Switzerland
CEIT-Cancer funding source(s)
Supported by the Swiss Cancer League (KLS-3587-02-2015), a grant from the Laura and John Arnold Foundationand the Stiftung Institut für klinische Epidemiologie.

CEIT-Cancer reviews

star_border star_border star_border star_border star_border
star star star star star

Be the first to review CEIT-Cancer